A Case of a Senile Systemic Amyloidosis Patient Presenting With Angina Pectoris and Dilated Cardiomyopathy by Kang, Gu Hyun et al.
209
Print ISSN 1738-5520 / On-line ISSN 1738-5555
Copyright © 2011 The Korean Society of Cardiology
CASE REPORT
DOI 10.4070/kcj.2011.41.4.209
Open Access
A Case of a Senile Systemic Amyloidosis Patient Presenting  
With Angina Pectoris and Dilated Cardiomyopathy
Gu Hyun Kang, MD, Dong Ryeol Ryu, MD, Pil Sang Song, MD, Young Bin Song, MD,  
Joo-Yong Hahn, MD, Seung-Hyuck Choi, MD, and Hyeon-Cheol Gwon, MD 
Division of Cardiology, Cardiac and Vascular Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
ABSTRACT
A 77-year-old man visited our hospital complaining of aggravated exertional chest pain. He was diagnosed with syndrome X 
7 years ago and underwent medical treatment in a regional hospital. Coronary angiography and echocardiography did not 
show any significant abnormalities. On the seventh in-hospital day, cardiogenic shock developed and echocardiography 
showed a dilated left ventricular (LV) cavity and severe LV systolic dysfunction. We thus inserted an intra-aortic balloon pump 
for hemodynamic support and were forced to maintain it because of weaning failure several times. Finally, heart transplan-
tation was the decided necessary procedure. After successful heart transplantation, the biopsy specimen revealed a wild-type 
transthyretin deposition indicating senile systemic amyloidosis in the intramuscular coronary vessels and interstitium. Car-
diac biopsy at the 4-year follow-up showed no recurrence of amyloid deposition. (Korean Circ J 2011;41:209-212)
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Introduction
Angina pectoris with normal coronary arteries, positive tr-
eadmill exercise testing and negative coronary spasm testing 
can be diagnosed as cardiac syndrome X. Such cases generally 
have a good prognosis. Amyloid deposition in the intramus-
cular coronary vessels may also present as angina with nor-
mal coronary arteries. Prognosis varies according to the type 
of amyloid protein. Although vascular involvement is com-
mon in patients with amyloidosis, systemic amyloidosis pre-
senting with angina is rare. Manifestations of cardiac amy-
loidosis may include congestive heart failure, angina, syncope 
and sudden cardiac death. However, in clinical settings, it is 
uncommonly suspected and difficult to diagnose amyloido-
sis in patients complaining of chest pain with a normal coro-
nary artery (syndrome X).
We dealt with a patient with senile systemic amyloidosis 
(SSA) who presented with recurrent angina pectoris and then 
fell into dilated cardiomyopathy (DCM) with severe left ven-
tricular (LV) systolic dysfunction, who was then successfully 
treated with a heart transplantation.
Case
In May 2005, a 77-year-old man visited our emergency de-
partment (ED) complaining of chest pain. He had intermit-
tently experienced exertional chest pain since 1996. In 1998, 
he visited a regional university hospital with recurrent chest 
pain and was diagnosed with cardiac syndrome X. His symp-
toms improved with medical treatment, but intermittent chest 
pain continued to recur.
In July 2002, he was admitted to our hospital for surgical 
treatment of benign prostate hypertrophy. The treadmill test 
was performed because of his history of angina and the result 
was positive. Thus, coronary angiography (CAG) and echo-
cardiography were also performed, which showed no signif-
icant abnormalities. Medical treatment for syndrome X was 
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In May 2005, the patient visited our ED due to chest pain that 
was aggravated in both intensity and duration. He did not have 
an acute ill-looking appearance because the angina had sub-
sided. Physical examination did not reveal any specific abnor-
malities. Vital signs were stable. Complete blood cell counts, 
blood chemistries, electrolyte and cardiac enzymes were all 
within the normal range. CAG and echocardiography, which 
were performed with the suspicion of unstable angina, did not 
show any significant abnormalities. Chest computerized to-
mography showed no explicable findings. Thereafter, his hos-
pital course worsened rapidly. On the seventh hospital day, he 
complained of dyspnea with chest pain in a resting state. Car-
diogenic shock developed. Plain chest radiography showed 
pulmonary edema with bilateral pleural effusion. Echocar-
diography showed that the LV cavity in diastole was increas-
ed (59 mm) with severe global hypokinesia. LV ejection frac-
tion was 29% by the Simpson’s method, but LV wall thickness 
was normal. These findings were compatible with DCM ex-
cept for the normal LV wall thickness (Fig. 1). Therefore, we 
inserted an intra-aortic balloon pump (IABP) for hemody-
namic support. It was necessary to maintain the IABP, due 
to weaning failure several times. His condition was tolerable 
only with maximum IABP support; whenever we tried to 
wean the IABP, the patient could not tolerate to the weaning 
due to severe chest pain. In addition, urine output was de-
creased. 
Finally, we decided to perform heart transplantation, which 
was successfully performed on the 84th hospital day. The out-
er surface of the extracted heart specimen showed some fatty 
tissue and fragmented coronary vessels. The right coronary 
artery was relatively well preserved (the cut area measuring 
about 1 cm), and the serial sections revealed no intraluminal 
stenosis. Only the distal portion of the left anterior descend-
ing artery was contained in the specimen, and the serial sec-
tions were unremarkable. Grossly, there was no mural throm-
bus. The right ventricle, intraventricular septum and LV were 
all hypertrophied (especially the right ventricle), measuring 
0.9, 1.7 and 1.5 cm in thickness, respectively. The cut surface 
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Fig. 1. Echocardiographic findings. A: end diastolic period of previous exam (July 7, 2002). B: end systolic period of previous exam (July 7, 
2002). C: end diastolic period of this exam (June 23, 2005). D: end systolic period of this exam (June 23, 2005).
Fig. 2. Gross finding of the extracted heart specimen. There are no 
mural thrombi. The right ventricle, intraventricular septum and left 
ventricle were 0.9, 1.7 and 1.5 cm in thickness, respectively, all of 
which were hypertrophied. The cut surface of the heart muscles sh-
ows no infarcts or fibrosis.Gu Hyun Kang, et al.   211
of the heart muscle showed no infarct or fibrosis (Fig. 2). The 
surgical specimen revealed amyloid deposition in the intra-
muscular coronary vessels and interstitium (Fig. 3). Immu-
nohistochemical staining of amyloid protein was positive for 
transthyretin (TTR), but not for light chains. Genomic de-
oxyribonucleic acid analysis of the TTR exons did not iden-
tify any mutation. A final diagnosis of SSA was made. Dur-
ing a follow-up period of 4 years, the cardiac biopsy speci-
mens showed neither recurrence of amyloid deposition nor 
rejection. The patient is currently doing well. He is symptom-
free and his laboratory results show there are no abnormali-
ties indicating other organ involvement.
Discussion
Amyloidosis is a disorder caused by the deposition of fibril, 
composed of low molecular-weight subunits of a variety of 
serum proteins, in extracellular tissue. Many organs and sys-
tems, such as the heart, kidney, liver and autonomic nervous 
system can be involved. Systemic amyloidosis can be classified 
into primary (AL), secondary (AA), hemodialysis-associated, 
hereditary and senile systemic types. When the amyloidosis 
involves the heart, a variety of manifestations can be present-
ed, namely right-sided heart failure, angina, syncope or pre-
syncope, ischemic stroke due to intra-cardiac thrombi and LV 
hypertrophy with restrictive physiology. Although heart in-
volvement in AL amyloidosis has a very poor prognosis, with 
an expected survival of 5 months, SSA has a relatively good 
prognosis.
1) According to an autopsy study, SSA is a frequent 
finding in elderly people. Cornwell et al.
2) demonstrated that 
approximately 50% of patients over the age of 60 years had 
senile cardiac amyloidosis.
There have been many case reports about symptomatic is-
chemic heart disease resulting from obstructive intramural 
coronary amyloidosis.
3-11) The involved vessels are typically sm-
all and intramyocardial. On the other hand, since the epicardi-
al coronary arteries are typically spared, CAG has normal or 
clinically insignificant findings.
3)4)9)10) Cardiac amyloidosis is 
very rarely presented as DCM.
5)12-14) In most cases of cardiac 
amyloidosis, echocardiographic features include ventricular 
atrial wall thickening and normal size of the ventricular-ch-
amber, unlike hypertrophic cardiomyopathy. However, echo-
cardiographic features in DCM caused by intracoronary am-
yloidosis are global hypokinesia of the LV with dilated LV ca-
vity and normal LV wall thickness.
15) 
Our case is the first report that recurrent and progressive 
angina pectoris and DCM developed sequentially in SSA. The 
pathogenesis of DCM in cardiac amyloidosis has not yet been 
established. In our case, DCM developed just after the presen-
tation of unstable angina. The surgical specimen revealed no 
fibrosis in the myocardium. Based on this finding it is con-
ceivable that DCM could develop as a result of severe persis-
tent myocardial ischemia in SSA. Considering the absence of 
fibrosis in our patient’s myocardium, the myocardium may 
have been in a hibernating state at that time. Although a hiber-
nating myocardium is a reversible state, in this case, it seem-
ed to be irreversible due to the progression of coronary amy-
loidosis. 
Actually, it is uncommon to suspect, and difficult to diag-
nose amyloidosis in patients presenting with angina before 
autopsy or heart biopsy is performed. Because an accurate di-
agnosis has a significant influence on the management and 
prognosis, clinicians have to consider amyloidosis as a differ-
ential diagnosis in the evaluation of angina pectoris patients 
with a normal coronary arteries. Endomyocardial biopsy sh-
ould be considered as a diagnostic method in suspicious pa-
Fig. 3. Light microscopic findings of vascular amyloid deposition. A: hematoxylin-eosin staining shows deposition of pale-staining amorphous 
material in both blood vessel and interstitium (original magnification ×100). B: congo red staining with cross-polarized microscopy shows 
that a green birefringence characteristic of amyloid is apparent (original magnification ×100).
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tients,
16)17) though endomyocardial biopsy is not always re-
quired; biopsy of the skin, rectal mucosa, lung and aspirated 
abdominal fat are useful for its definitive diagnosis instead. 
As shown in our case, SSA does not recur in a transplanted he-
art
18) while AL amyloidosis usually does progress into the tr-
ansplanted heart.
19)20) Therefore, heart transplantation can be 
an effective therapeutic option in SSA patients who do not res-
ponse to intensive medical treatment.
18) 
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